why choose us

First received: August 11, 2024

Clinical Trial: Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Single/Multiple Dose Escalation, Placebo-controlled Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CM512

Brief Summary: This is a randomized, double-blind, single/multiple dose escalation, placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of CM512 in healthy subjects and patients with moderate to severe atopic dermatitis.

Read more